Experimental model of warfarin-associated intracerebral hemorrhage
about
Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCCIntravenous tPA therapy does not worsen acute intracerebral hemorrhage in miceEffects of propolis on warfarin efficacyAnticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.Characterization of the brain injury, neurobehavioral profiles, and histopathology in a rat model of cerebellar hemorrhage.Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage.Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhageComparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhageExperimental intracerebral hemorrhage: avoiding pitfalls in translational research.What sequences on high-field MR best depict temporal resolution of experimental ICH and edema formation in mice?Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.Rodent neonatal germinal matrix hemorrhage mimics the human brain injury, neurological consequences, and post-hemorrhagic hydrocephalus.Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathwayFollowing experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signalingInhibition of 12/15-lipoxygenase as therapeutic strategy to treat strokeTreatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage.A novel preclinical model of germinal matrix hemorrhage using neonatal rats.The postpartum period of pregnancy worsens brain injury and functional outcome after cerebellar hemorrhage in rats.Evaluation of the hematoma consequences, neurobehavioral profiles, and histopathology in a rat model of pontine hemorrhage.Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studiesThe glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.Intracerebral haemorrhage: mechanisms of injury and therapeutic targets.Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.Do current animal models of intracerebral hemorrhage mirror the human pathology?The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion.Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhageAutologous blood injection to model spontaneous intracerebral hemorrhage in mice.Anticoagulation increases alveolar hemorrhage in mice infected with influenza A.Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban.Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis.Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.Rho-kinase inhibitors do not expand hematoma volume in acute experimental intracerebral hemorrhage.
P2860
Q27316789-BD811026-D581-44CD-A5AF-F6C49B95034FQ27320059-110707ED-AEF4-40D3-8AD7-EE882C90F086Q33600585-BAA6510C-61CD-45E9-8FE0-2EA96551FFC6Q34017336-7269C002-E520-4290-A256-BA6BD28B7403Q34482285-797F3D2F-AA03-412A-8ABF-7C5386E3C4CCQ34554517-2F4DF002-4714-4D16-8003-6DCD194EB724Q35208004-308632CF-A13B-4F58-8D4E-DC106275733DQ35365120-529F776D-582F-4333-BA90-0F0FA6B923B4Q35534164-645FCE0B-008B-4D49-B5BC-EBC3179E3D1CQ35955931-3B66B921-D65A-4EC4-B7E4-E88A87219915Q35993214-53679780-404E-457E-903B-EEDC329DC4B6Q36007449-5CBCA541-E213-47BF-8566-5DFB7FE94A28Q36198189-436DFFC1-9F87-4566-A406-146954A702A7Q36534341-24C305CC-C5B9-407D-9B40-1E90FFF171ADQ36586036-1A3FEC58-6E96-4A80-868A-5F43D2265EF6Q36591931-6C75964C-F96F-4041-B673-E5AC2209B43FQ36600489-FE59101F-F939-49FB-9599-805F89BEFD8AQ36600511-A6104427-03D4-48B1-A6B6-F2D79CE354B6Q36600521-13B9B739-AC26-4F0D-8C7C-1449CD72C823Q36953704-12976633-2E94-43FC-86D9-503925DFD1AFQ36984232-E071F945-671D-4E63-9A89-CEE36C2A6017Q37211999-21C7A137-3941-4D02-BB82-666688F29B07Q37448194-5AC9C61C-FFDB-46D6-9328-6F13D5C3B996Q37659809-F4FA2A69-5CB0-4A59-A240-AE8FBD94B1F1Q37701367-55B41017-6E54-44B9-A71E-D8055A4FEC44Q37873969-7C84F797-1999-4FF9-B2DB-968D793E4474Q38113483-4959A4C2-1EC7-4CAE-94B0-80AAAEB7566DQ38170028-0BABD496-3F33-44FC-97AA-505E0EA11401Q38527557-16F92A54-1006-4C3D-A055-4A88D2D413FDQ38873721-998BCA24-252F-4BFF-A358-B4AE33A67E61Q39149277-2DC47529-FAF4-410F-B42C-12F43BAD8738Q40399798-04C09BD8-FCD7-4DFC-9BCB-65F8DAC7B6EEQ40749422-08D5EF12-6E0D-4CD3-A4C3-C82C73872350Q42013348-8D971696-6863-49EE-A688-BA0B27AF91C5Q43075526-CD48E316-4FE4-4325-A5F8-A0F2798E2240Q46489865-6A8FCFCE-6633-4BB3-A327-03ECBB21FB6CQ48346851-F39D93B1-6CF2-435D-AB85-3102CB21628FQ48370582-2EF20211-7EFE-4ABC-BBE2-F927FE9800E3Q48447356-98EB5047-A5ED-49E1-8AAD-BCD821CB01BFQ55405303-F7A4EA71-A6A4-4923-BBF2-A385B7F83E83
P2860
Experimental model of warfarin-associated intracerebral hemorrhage
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental model of warfarin-associated intracerebral hemorrhage
@en
Experimental model of warfarin-associated intracerebral hemorrhage.
@nl
type
label
Experimental model of warfarin-associated intracerebral hemorrhage
@en
Experimental model of warfarin-associated intracerebral hemorrhage.
@nl
prefLabel
Experimental model of warfarin-associated intracerebral hemorrhage
@en
Experimental model of warfarin-associated intracerebral hemorrhage.
@nl
P2093
P2860
P1433
P1476
Experimental model of warfarin-associated intracerebral hemorrhage
@en
P2093
Christian Foerch
Klaus van Leyen
Kyung-Pil Park
Stefanie Pallast
P2860
P304
P356
10.1161/STROKEAHA.108.517482
P407
P577
2008-09-04T00:00:00Z